Merryman explains the value of evaluating separate transplant-related questions for patients with relapsed or refractory diffuse large B-cell lymphoma.
Thought leader detailed the findings from an oral presentation investigating patients with relapsed or refractory diffuse large B-cell lymphoma.
Merryman provided background for the study design investigating patients with relapsed or refractory diffuse large B-cell lymphoma.